---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-011751"
form_type: "8-K"
ticker: "DSGN"
cik: "0001807120"
company_name: "Design Therapeutics, Inc."
filed_at: "2022-06-16T23:59:59+00:00"
generated_at: "2026-06-25T01:21:52.805648+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Design Therapeutics stockholders elect three directors, ratify EY as auditor at 2022 annual meeting

## Summary
- Shareholders elected Heather Berger, Rodney Lappe, and John Schmid as Class I directors to serve until 2025.
- Votes for Berger: 49,858,607; for Lappe: 49,543,074; for Schmid: 49,344,059; with ~1.94M broker non-votes each.
- Ratification of Ernst & Young as independent auditor for FY2022 passed with 53,181,814 votes for, 542 against, 36 abstentions.
- Meeting held June 15, 2022; 55,781,681 shares outstanding and entitled to vote as of record date April 18, 2022.

## SEC filing metadata
- accession: 0000950170-22-011751
- form_type: 8-K
- ticker: DSGN
- cik: 0001807120
- company_name: Design Therapeutics, Inc.
- filed_at: 2022-06-16T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1807120/000095017022011751/0000950170-22-011751-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1807120/000095017022011751/dsgn-20220615.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-011751
- JSON: https://secwatch.observer/filing/0000950170-22-011751.json
- Plain text: https://secwatch.observer/filing/0000950170-22-011751.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.